Bahattin TUNCALI, Gizem CABBAROĞLU, Ayse Gül TEMİZKAN KIRKAYAK, Pınar ZEYNELOĞLU

Akciğer Kanserine Bağlı Kemik Metastazı ID Nedeniyle Gelişen Şiddetli Hiperkalsemide Sürekli Venö-Venöz Hemodiyafiltrasyon: Bir Olgu Sunumu

En sık olarak neoplastik hastalıklar ve primer hiperparatiroidi nedeniyle gelişen şiddetli hiperkalsemi, nörolojik, kardiyovasküler ve renal fonksiyonlarda ciddi bozulmalara yol açabilen, nadir ancak yaşamı tehdit edici bir elektrolit bozukluğudur. Bu makalede, metastatik akciğer kanserine bağlı ciddi hiperkalsemi, akut böbrek hasarı ve bozulmuş hemodinami nedeniyle yoğun bakımda sürekli venö-venöz hemodiyafiltrasyon (CVVHDF) ve destek tedavisi ile başarıyla tedavi edilen olguyu sunduk.

Continuous Veno-Venous Hemodiafiltration in Severe Hypercalcemia Due to Metastatic Lung Cancer: A Case Report

Severe hypercalcemia most often caused by neoplastic diseases and primary hyperparathyroidism is a rare but life-threatening electrolyte disorder which can lead to serious impairments in neurological, cardiovascular and renal functions. Herein, we present a patient with severe hypercalcemia due to metastatic lung cancer, acute kidney injury and impaired hemodynamics who was successfully treated with continuous veno-venous hemodiafiltration (CVVHDF) and supportive therapy in intensive care unit.

PDF

___

1. Mousseaux C, Dupont A, Rafat C, ve ark. Epidemiology, clinical features, and management of severe hypercalcemia in critically ill patients. Ann Intensive Care. 2019;9:133. https://doi.org/10.1186/s13613-019-0606-8
2. Carrick AI, Costner HB. Rapid Fire: Hypercalcemia. Emerg Med Clin North Am. 2018;36:549-55. https://doi.org/10.1016/j.emc.2018.04.008
3. Halfdanarson T, Hogan W, Moynihan TJ. Oncologic emergencies: diagnosis and treatment. Mayo Clin Proc. 2006;81:835-48. https://doi.org/10.4065/81.6.835
4. Goldner W. Cancer-Related Hypercalcemia. J Oncol Pract. 2016;12:426-32. https://doi.org/10.1200/JOP.2016.011155
5. Zagzag J, Hu MI, Fisher SB, Perrier ND. Hypercalcemia and cancer: Differential diagnosis and treatment. CA Cancer J Clin. 2018;68:377-86. https://doi.org/10.3322/caac.21489
6. Sternlicht H, Glezerman IG. Hypercalcemia of malignancy and new treatment options. Ther Clin Risk Manag. 2015;11:1779-88. https://doi.org/10.2147/TCRM.S83681
7. Basok AB, Rogachev B, Haviv YS, Vorobiov M. Treatment of extreme hypercalcaemia: the role of haemodialysis. BMJ Case Rep. 2018 pii: bcr-2017-223772. https://doi.org/10.1136/bcr-2017-223772
8. Bentata Y, El Maghraoui H, Benabdelhak M, Haddiya I. Management of hypercalcaemic crisis in adults: Current role of renal replacement therapy. Am J Emerg Med. 2018;36:1053-6. https://doi.org/10.1016/j.ajem.2018.03.011
9. Wang CC, Chen YC, Shiang JC, Lin SH, Chu P, Wu CC. Hypercalcemic crisis successfully treated with prompt calcium-free hemodialysis. Am J Emerg Med. 2009;27:1174.e1-e3. https://doi.org/10.1016/j.ajem.2009.01.026
10. Loh HH, Mohd Noor N. The use of hemodialysis in refractory hypercalcemia secondary to parathyroid carcinoma. Case Rep Crit Care. 2014;2014:140906. https://doi.org/10.1155/2014/140906
11. vanKuijk WH, Mulder AW, Peels CH, Harff GA, Leunissen KM. Influence of changes in ionized calcium on cardiovascular reactivity during hemodialysis. Clin Nephrol. 1997;47:190-6.
12. Khwaja A. KDIGO Clinical Practice Guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:179-84. https://doi.org/10.1159/000339789
13. Kyriazis J, Stamatiadis D, Mamouna A. Intradialytic and interdialytic effects of treatment with 1.25 and 1.75 mmol/L of calcium dialysate on arterial compliance in patients on hemodialysis. Am J Kidney Dis. 2000;35:1096103. https://doi.org/10.1016/S0272-6386(00)70046-1